Home/Acelot/Marcie Glicksman, PhD
MG

Marcie Glicksman, PhD

Acting Chief Scientific Officer

Acelot

Roles

Acting Chief Scientific OfficeratAcelot
VP BiologyatEnClear Therapies

Acelot Pipeline

DrugIndicationPhase
ACE-2223Amyotrophic Lateral Sclerosis (ALS)Preclinical